Report highlights "disastrous" effect of EU proposal on MRI
This article was originally published in RAJ Devices
The European Science Foundation has issued a position paper urging stakeholders to act to prevent the implementation of European Union legislation that could adversely affect the use of magnetic resonance imaging in medical research and clinical settings1,2.
You may also be interested in...
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.